Transforming T Cell Manufacturing via Elutriation with Korus™ Webinar Video
Michelle Duquette, Director of Business Development, Cell Therapy discusses how the closed Korus system could streamline and improve your cell and gene therapy manufacturing process from process development to GMP production.
Learn from Invetech’s experts on the new Korus system! Watch this webinar to learn how Korus uses a gentle elutriationprocess to give you a cleaner cell population to begin cell therapy production processes such as CAR-T, dendritic cell, tumor-infiltratedlymphocytes (TIL), or IPSC-derived.
Discussion topics include:
How incorporating lymphocyte elutriation into your T cell therapy manufacturing process can consistently improve your overall cell yield by up to 2.5X compared to a standard wash process
The effects of using cleaner lymphocyte populations produced by the Korus on downstream manufacturing operations such as cell selection and expansion
Early unpublished data on our monocyte elutriation protocol
Would you like to learn more about the new Korus system?
Learn how Korus can help you start your manufacturing process with cleaner lymphocyte or monocyte populations! Connect with an Invetech team member now!
The Korus system is for research, laboratory or further manufacturing use only. It is not intended as a medical device in therapeutic or diagnostic procedures. Customers are responsible for validating the use of Korus within their process or therapy. Consult all instructions, terms and warnings prior to use of the solutions and products. Failure to do so can result in damage or serious injury, including death. Ready-to-run turnkey systems may require minor configuration before sale and use depending on customer needs.